|
| 华恒生物(688639)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-05-19 | 25.23 | 0.16% | 15781.03 | 0.00 | 15763.63 | 99.89% | 股权激励限售股份 | | 2025-04-28 | 2112.25 | 9.24% | 22834.92 | 25.23 | 22834.92 | 99.89% | 定向增发机构配售股份 | | 2024-06-17 | 17.40 | 0.11% | 15736.62 | 17.40 | 15719.22 | 99.78% | 股权激励限售股份 | | 2024-04-22 | 5525.19 | 35.15% | 15683.20 | 34.80 | 10134.81 | 64.48% | 首发原股东限售股份 | | 2023-09-04 | 36.02 | 0.23% | 10158.01 | 5559.99 | 10158.01 | 64.63% | 股权激励一般股份 | | 2023-07-03 | 23.20 | 0.15% | 10158.01 | 5559.99 | 10134.81 | 64.48% | 股权激励限售股份 | | 2023-04-24 | 135.00 | 1.25% | 6989.53 | 3850.47 | 6986.52 | 64.45% | 首发战略配售股份 | | 2022-04-22 | 4375.45 | 40.36% | 6854.53 | 3985.47 | 6854.53 | 63.23% | 首发原股东限售股份,首发战略配售股份 |
|